Pfizer is leaving no stone unturned in its efforts to prevent Novo Nordisk from stealing off with Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.

A notice on top of its website says "the well has run dry." The Department of Agriculture has posted a notice on its website warning that Supplemental Nutrition Assistance Program (SNAP) benefits ...